CCR3 and myeloid sarcoma: The results of our study indicates higher expression of Th1-associated chemokine receptors CD4+CXCR3+ on peripheral T cells and lower expression of Th2-associated chemokine receptors such as CD4+CCR3+ in MS patients than in HC, which is in accordance with the results of the above-mentioned reports.